Eluvia
Payments companies reported to CMS as associated with Eluvia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Eluvia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Eluvia
These are the largest totals companies reported as associated with Eluvia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mohammad Ansari | Lubbock, TX | Interventional Cardiology | $16,210.51 |
| Sonya Noor | Buffalo, NY | Vascular Surgery | $15,094.46 |
| Elizabeth Genovese | Philadelphia, PA | Vascular Surgery | $13,980.34 |
| Damian Grovas Abad | San Juan, PR | Interventional Cardiology | $11,875.00 |
| Anahita Dua | Boston, MA | Vascular Surgery | $11,100.00 |
| Erin Murphy | Charlotte, NC | Vascular Surgery | $9,678.50 |
| Jeffrey Hnath | Albany, NY | Vascular Surgery | $9,401.26 |
| Byung Park | Dallas, TX | Interventional Cardiology | $8,750.27 |
| Patrick Harty | Sacramento, CA | Vascular & Interventional Radiology | $8,147.49 |
| Yolanda Bryce | New York, NY | Diagnostic Radiology | $8,121.75 |
Prescribed Eluvia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.